Bio Preventive Medicine Corp. (TPEX:6810)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
30.85
-2.15 (-6.52%)
Apr 29, 2026, 2:00 PM CST
30.17%
Market Cap 1.63B
Revenue n/a
Net Income n/a
Shares Out 49.45M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 293,131
Average Volume 494,227
Open 33.00
Previous Close 33.00
Day's Range 30.65 - 33.10
52-Week Range 16.50 - 46.00
Beta -0.15
RSI 63.11
Earnings Date n/a

About Bio Preventive Medicine

Bio Preventive Medicine Corp., a clinical-staged biotech company, focusing on early detection and prevention of diseases. The company offers solutions in prevention, screening, and monitoring chronic diseases and cancers management. It also provides DNlite test, a series of patented and clinically validated non-invasive urine test for monitoring the progression of diabetic nephropathy, including DNlite-IVD103 and DNlite-DN_Score. Bio Preventive Medicine Corp. was founded in 2014 and is headquartered in Zhubei, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6810
Full Company Profile

News

There is no news available yet.